Valuation: EUROAPI

Market Cap 74.89M 85.9M 70.54M 64.24M 120M 8.23B 121M 845M 326M 4.19B 323M 316M 13.53B P/E 2026 *
-0.61x
P/E 2027 * -1.49x
Enterprise Value 94.18M 108M 88.7M 80.78M 151M 10.35B 152M 1.06B 409M 5.27B 406M 397M 17.01B EV / Sales 2026 *
0.13x
EV / Sales 2027 * 0.18x
Free-Float
64.75%
Yield 2026 *
-
Yield 2027 * -
1 day-2.24%
1 week-7.22%
Current month-14.88%
1 month-20.33%
3 months-37.28%
6 months-40.02%
Current year-65.36%
1 week 0.78
Extreme 0.781
0.86
1 month 0.78
Extreme 0.781
0.97
Current year 0.78
Extreme 0.781
2.26
1 year 0.78
Extreme 0.781
3.41
3 years 0.78
Extreme 0.781
12.16
5 years 0.78
Extreme 0.781
18.92
10 years 0.78
Extreme 0.781
18.92
Manager TitleAgeSince
Chief Executive Officer - 09/12/2024
Director of Finance/CFO - 17/10/2024
Compliance Officer - 27/11/2023
Director TitleAgeSince
Director/Board Member 62 06/05/2022
Director/Board Member - 06/05/2022
Chairman 57 09/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
-2.24%-7.22% - - 85.45M
+1.04%+2.34%+54.91%+111.75% 1,028B
-0.19%+1.18%+52.94%+66.69% 651B
+0.20%+1.04%+18.88%+72.38% 466B
+2.24%+0.94%+37.61%+45.31% 346B
+0.90%+1.95%+18.79%+25.27% 266B
+0.48%+3.34%+11.11%+15.38% 259B
+1.95%+3.06%+37.75%+45.93% 208B
-7.65%-7.28%-33.09%-59.52% 191B
+0.30%+2.83%+31.97%+100.03% 186B
Average -0.21%+2.45%+25.65%+47.02% 400.19B
Weighted average by Cap. +0.56%+2.23%+35.56%+65.31%

Financials

2026 *2027 *
Net sales 753M 863M 709M 646M 1.21B 82.71B 1.21B 8.49B 3.27B 42.13B 3.24B 3.17B 136B 760M 872M 716M 652M 1.22B 83.54B 1.22B 8.58B 3.31B 42.56B 3.28B 3.2B 137B
Net income -122M -139M -115M -104M -196M -13.36B -196M -1.37B -529M -6.81B -524M -512M -21.97B -50.07M -57.42M -47.15M -42.94M -80.51M -5.5B -80.61M -565M -218M -2.8B -216M -211M -9.04B
Net Debt 19.28M 22.12M 18.16M 16.54M 31.01M 2.12B 31.05M 218M 83.83M 1.08B 83.08M 81.24M 3.48B 61.91M 71.01M 58.31M 53.1M 99.56M 6.8B 99.69M 698M 269M 3.47B 267M 261M 11.18B
Logo EUROAPI
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 5 production sites located in France (2), Germany, Italy and Hungary.
Employees
2,961
Date Price Change Volume
21/09/26 €0.7850 -2.12% 17,260
18/09/26 €0.8020 -5.65% 7,453
17/09/26 €0.8500 -1.05% 13,887
16/09/26 €0.8590 +1.30% 922
15/09/26 €0.8480 +0.36% 33,270
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
4
Last Close Price
0.7840EUR
Average target price
1.150EUR
Spread / Average Target
+46.68%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!